Sofinnova Partners

Quester

Astellas Venture Management LLC

Takeda Research Investment

Sulis Seedcorn Fund

 

Astellas Venture Management LLC

www.astellasventure.com

 

Astellas Venture Management LLC. (AVM, Los Altos, CA, USA) is the corporate venture capital arm of Astellas Pharma Inc., a global pharmaceutical company headquartered in Tokyo, Japan, which was formed through the merger of Fujisawa Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. in April 2005. AVM’s investment objective is to find out a venture company with a proprietary technology and facilitate its growth by utilizing Astellas’ experience and network within biotechnology field. AVM’s ability to offer not only investment funds, but also the Astellas Group’s powerful combination of scientific and technical expertise, depth of drug development and marketing knowledge and long-term business perspective, can give entrepreneurs and investors the very best chance for their rapid growth and success. For more information on Astellas, please visit the company’s website at www.astellas.com.

 
         

Lectus Therapeutics Ltd. 2003–2008

Registered Offices: 123 Deansgate Manchester M3 2BU
Company Number: 4562659 Given in Manchester